PKR is a key component of the interferon-induced antiviral pathway in higher eukaryotes. Upon recognition of viral dsRNA, PKR is activated via dimerization and autophosphorylation. PKR contains two N-terminal dsRNA binding domains (dsRBD) and a C-terminal kinase domain. The dsRBDs and the kinase are separated by a long, unstructured ~80 amino acid linker in the human enzyme. The length of the N-terminal portion of the linker varies among PKR sequences and it is completely absent in one ortholog. Here, we characterize the effects of deleting the variable region from the human enzyme to produce PKRΔV. The linker deletion results in quantitative but not qualitative changes in catalytic activity, RNA binding and conformation. PKRΔV is somewhat more active and exhibits more cooperative RNA binding. As we previously observed for the full-length enzyme, PKRΔV is flexible in solution and adopts a range of compact and extended conformations. The conformational ensemble is biased towards compact states which may be related to weak interactions between the dsRBD and kinase domains. PKR retains RNA-induced autophosphorylation upon complete removal of the linker, indicating that the C-terminal, basic region is also not required for activity.
PKR is a key component of the interferon-induced antiviral pathway in higher eukaryotes.1,2 Upon recognition of intracellular dsRNA of 30 bp or longer it is activated via dimerization and autophophorylation.3 Activated PKR phosphorylates eIF2α, which locks the eIF2A heterotrimer in a GDP bound complex incapable of binding Met-tRNA and initiating translation. Consequently, protein synthesis is halted, leading to apoptosis and containment of the viral infection. In addition, PKR is involved in a plethora of signaling pathways involving stress response and inflammation and regulates cellular growth and proliferation, nutrient signaling and metabolism.4–6